185 related articles for article (PubMed ID: 20586795)
1. Plasma and cellular contributions to fibrin network formation, structure and stability.
Wolberg AS
Haemophilia; 2010 May; 16 Suppl 3():7-12. PubMed ID: 20586795
[TBL] [Abstract][Full Text] [Related]
2. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.
Campbell RA; Overmyer KA; Selzman CH; Sheridan BC; Wolberg AS
Blood; 2009 Nov; 114(23):4886-96. PubMed ID: 19797520
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation, fibrin clot formation and hemostasis.
Wolberg AS; Campbell RA
Transfus Apher Sci; 2008 Feb; 38(1):15-23. PubMed ID: 18282807
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation.
Hoppe B
Thromb Haemost; 2014 Oct; 112(4):649-58. PubMed ID: 25182841
[TBL] [Abstract][Full Text] [Related]
5. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.
von dem Borne PA; Meijers JC; Bouma BN
Blood; 1995 Oct; 86(8):3035-42. PubMed ID: 7579397
[TBL] [Abstract][Full Text] [Related]
6. Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots.
Zubairova LD; Nabiullina RM; Nagaswami C; Zuev YF; Mustafin IG; Litvinov RI; Weisel JW
Sci Rep; 2015 Dec; 5():17611. PubMed ID: 26635081
[TBL] [Abstract][Full Text] [Related]
7. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
Bouma BN; Meijers JC
Semin Hematol; 2004 Jan; 41(1 Suppl 1):13-9. PubMed ID: 14872415
[TBL] [Abstract][Full Text] [Related]
8. Normal haemostasis and its regulation.
Mackie IJ; Bull HA
Blood Rev; 1989 Dec; 3(4):237-50. PubMed ID: 2692745
[TBL] [Abstract][Full Text] [Related]
9. The coagulation system in humans.
Chan AK; Paredes N
Methods Mol Biol; 2013; 992():3-12. PubMed ID: 23546701
[TBL] [Abstract][Full Text] [Related]
10. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.
Campbell RA; Overmyer KA; Bagnell CR; Wolberg AS
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2247-54. PubMed ID: 18974382
[TBL] [Abstract][Full Text] [Related]
11. General haemostatic agents--fact or fiction?
Hedner U
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
[TBL] [Abstract][Full Text] [Related]
12. Thrombin generation and fibrin clot structure.
Wolberg AS
Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
[TBL] [Abstract][Full Text] [Related]
13. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
14. The haemostatic balance -- Astrup revisited.
Gaffney PJ; Edgell TA; Whitton CM
Haemostasis; 1999 Sep; 29(1):58-71. PubMed ID: 10494035
[TBL] [Abstract][Full Text] [Related]
15. Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.
Mitrophanov AY; Wolberg AS; Reifman J
Mol Biosyst; 2014 Jul; 10(9):2347-57. PubMed ID: 24958246
[TBL] [Abstract][Full Text] [Related]
16. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
Torbet J
Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
[TBL] [Abstract][Full Text] [Related]
17. Sticky and promiscuous plasma proteins maintain the equilibrium between bleeding and thrombosis.
Furlan M
Swiss Med Wkly; 2002 Apr; 132(15-16):181-9. PubMed ID: 12070783
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen and fibrin.
Weisel JW
Adv Protein Chem; 2005; 70():247-99. PubMed ID: 15837518
[TBL] [Abstract][Full Text] [Related]
19. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis.
Bouma BN; Mosnier LO
Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):375-81. PubMed ID: 15692247
[TBL] [Abstract][Full Text] [Related]
20. [Besides fibrinogen, are haemostatic, coagulation and/or fibrinolytic parameters predictors or markers of the risk of cardiovascular events?].
Drouet L; Bal dit Sollier C
Therapie; 2005; 60(2):137-47. PubMed ID: 15969316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
